Franz B Humer - Net Worth and Insider Trading
Franz B Humer Net Worth
The estimated net worth of Franz B Humer is at least $476,636 dollars as of 2025-04-28. Franz B Humer is the Director of Allogene Therapeutics Inc and owns about 307,507 shares of Allogene Therapeutics Inc (ALLO) stock worth over $476,636. Details can be seen in Franz B Humer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Franz B Humer has not made any transactions after 2024-12-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Franz B Humer
Franz B Humer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Franz B Humer owns 3 companies in total, including Allogene Therapeutics Inc (ALLO) , Citigroup Inc (C) , and Kite Pharma Inc (KITE) .
Click here to see the complete history of Franz B Humer’s form 4 insider trades.
Insider Ownership Summary of Franz B Humer
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
ALLO | Allogene Therapeutics Inc | 2024-12-05 | director |
C | Citigroup Inc | 2012-04-17 | director |
KITE | Kite Pharma Inc | 2017-10-03 | director |
Franz B Humer Latest Holdings Summary
Franz B Humer currently owns a total of 1 stock. Franz B Humer owns 307,507 shares of Allogene Therapeutics Inc (ALLO) as of December 5, 2024, with a value of $476,636.
Latest Holdings of Franz B Humer
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ALLO | Allogene Therapeutics Inc | 2024-12-05 | 307,507 | 1.55 | 476,636 |
Holding Weightings of Franz B Humer
Franz B Humer Form 4 Trading Tracker
According to the SEC Form 4 filings, Franz B Humer has made a total of 2 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Allogene Therapeutics Inc is the sale of 9,221 shares on December 5, 2024, which brought Franz B Humer around $19,917.
Insider Trading History of Franz B Humer
- 1
Franz B Humer Trading Performance
GuruFocus tracks the stock performance after each of Franz B Humer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Franz B Humer is 3.67%. GuruFocus also compares Franz B Humer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Franz B Humer within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Franz B Humer's insider trading performs compared to the benchmark.
Performance of Franz B Humer
Franz B Humer Ownership Network
Ownership Network List of Franz B Humer
Ownership Network Relation of Franz B Humer

Franz B Humer Owned Company Details
What does Allogene Therapeutics Inc do?
Who are the key executives at Allogene Therapeutics Inc?
Franz B Humer is the director of Allogene Therapeutics Inc. Other key executives at Allogene Therapeutics Inc include director & President and CEO David D Chang , GENERAL COUNSEL Earl Martin Douglas , and EVP of R&D Zachary Roberts .
Allogene Therapeutics Inc (ALLO) Insider Trades Summary
Over the past 18 months, Franz B Humer made 2 insider transaction in Allogene Therapeutics Inc (ALLO) with a net sale of 20,421. Other recent insider transactions involving Allogene Therapeutics Inc (ALLO) include a net sale of 59,730 shares made by Deborah M. Messemer , a net sale of 92,671 shares made by David D Chang , and a net sale of 46,031 shares made by Zachary Roberts .
In summary, during the past 3 months, insiders sold 165,416 shares of Allogene Therapeutics Inc (ALLO) in total and bought 0 shares, with a net sale of 165,416 shares. During the past 18 months, 259,453 shares of Allogene Therapeutics Inc (ALLO) were sold and 1,724,327 shares were bought by its insiders, resulting in a net purchase of 1,464,874 shares.
Allogene Therapeutics Inc (ALLO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Allogene Therapeutics Inc Insider Transactions
Franz B Humer Mailing Address
Above is the net worth, insider trading, and ownership report for Franz B Humer. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Franz B Humer's mailing address is: New York Ny 10013.